| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.06 |